Fundamental dimension Equity attribute | DNAPeer $9.99▲+2.88% Cap $672.7MP/E -2.0x QuantScore30/100 | ARVNPeer $7.30▼-5.44% Cap $471.0MP/E 38.4x QuantScore51/100 | ATXSLeader $12.580.00% Cap $718.1MP/E -11.2x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
71/100 |
48/100 |
57/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 15/100 | 25/100 |
Health Piotroski, Altman Z, leverage & liquidity | 39/100 | 67/100 | 79/100 |
Growth Revenue / earnings growth & margins | 38/100 | 68/100 | 50/100 |
Sentiment Analyst ratings, targets & revisions | 4/100 | 57/100 | 56/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.0x | 38.4x | -11.2x |
Forward P/E (next FY) | -2.6x | -179.3x | -6.3x |
EV / EBITDA (TTM) | -4.1x | 98.7x | -9.7x |
Price / Sales | 6.0x | 1.5x | 1017.2x |
Price / Free Cash Flow | -3.5x | -2.3x | -10.4x |
PEG ratio | -0.13 | -0.21 | 1.37 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 6 / 9 | 3 / 9 |
Altman Z-Score | -8.73 (Distress) | 0.87 (Distress) | 6.69 (Safe) |
Total debt / equity | 0.96 | 0.01 | 0.02 |
Quick ratio | 4.6x | 7.9x | 10.8x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -25.1% | -0.3% | — |
Net income growth YoY | +42.8% | +59.4% | -29.3% |
Gross margin (TTM) | 80.1% | 96.4% | 100.0% |
Operating margin (FY) | -185.3% | -43.8% | — |
FCF margin (FY) | -105.0% | -105.0% | — |
5. Trailing price performancePrice change over period |
1M return | -2.5% | -6.3% | 0.0% |
3M return | +35.7% | -9.1% | +0.6% |
6M return | +26.9% | -30.1% | +85.3% |
Year to date | +20.2% | -38.4% | -2.4% |
1Y return | -26.4% | -20.7% | +92.6% |
3Y return | -84.1% | -50.5% | -4.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-30.33 -403.6% premium | $-110.73 -1616.9% premium | $0.8964 -92.9% premium |
Wall Street consensus target | $5.00 -49.9% · range $5.00–$5.00 | $14.17 +94.1% · range $10.00–$20.00 | $19.40 +54.2% · range $13.00–$26.00 |
Consensus stance | 36% Buy27% Hold36% Sell | 73% Buy23% Hold4% Sell | 38% Buy63% Hold0% Sell |